Journal list Promote Sponsor
verified SJR 1,646 · Q1 • database Scopus / SJR & Web of Science indexed
Genes and Diseases
China · KeAi Communications Co.
workspace_premium Q1 — Cell Biology visibility_off Single blind Peer Review lock_open Open Access

Genes and Diseases

Genes and Diseases is a journal indexed in SJR in Cell Biology and Molecular Biology with an H index of 63. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system The scope of the journal is focused on molecular genetics, cell biology, stem cell biology, gene regulation and epigenetics, immunity and infection, neuroscience. It has an SJR impact factor of 1,646 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,646.

Publisher: KeAi Communications Co.
Category: Cell Biology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,646 Q1
H-index 63
Acceptance rate pie_chart
32%
Source Acceptance_Rate
Time to publication hourglass_top
35 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
NPD Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,646

H-index

63

Docs (year)

348

Docs 3y

548

Total refs

17866

Cites 3y

3080

Citable 3y

535

Cites/Doc 2y

5.05

Ref/Doc

51.34

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs